InvestorsHub Logo

X Master

02/20/23 1:09 AM

#569191 RE: HyGro #569189

HyGro It's like 50 First Dates. We had the same conversation last night and your still wrong.
Bullish
Bullish

Dr Bala

02/20/23 1:18 AM

#569192 RE: HyGro #569189

Nonsensical statements after the best GBM trial results in history. Thanks so much, HyGro.

SkyLimit2022

02/20/23 2:51 PM

#569307 RE: HyGro #569189

This is verifiably false.

“Clinically appropriate” means that the trial treated the human participants as human and not as lab rats.

Regarding the landmark P3, the FDA would argue that the GBM patients were not lab rats, and the crossover design was necessary.





Skip to timestamp 8:01. Dr. Liau again confirms that the crossover was mandated by the FDA.
https://edhub.ama-assn.org/jn-learning/audio-player/18738384


https://www.annalsofoncology.org/article/S0923-7534(22)00006-0/fulltext

If you like traditional placebo trials, then you’ll love the PD1 combo trial. This trial doesn’t require crossover because all of the placebo participants have access to an efficacious therapy (100% of the placebo control group are receiving DCVax-L):

https://clinicaltrials.gov/ct2/show/NCT04201873





https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/

https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847


Bullish
Bullish